Literature DB >> 11206883

Self-reported disease awareness--a questionnaire survey of ulcerative colitis patients.

A Sood1, V Midha, N Sood, V Kaushal.   

Abstract

OBJECTIVE: To evaluate patient knowledge about ulcerative colitis and relate this to their socio-demographic characteristics.
METHODS: 145 patients with ulcerative colitis were given a two-sectioned awareness questionnaire in a language they understood. The first section, which tested disease awareness, consisted of 16 items. Awareness was classified as very low (< or = 4 correct answers), low (5-8), medium (9-12) and high (13-16). The second section contained 11 questions pertaining to general opinions and views about the disease.
RESULTS: Nine (6.2%) participants had very low level of awareness, 107 (73.8%) low level, 29 (20%) medium, and none high disease awareness. Only disease duration influenced disease awareness significantly. Age, sex, marital status, occupation and education level had no relation to the level of awareness. A majority of patients resorted to use of alternative medicines during their disease course; however, with increasing awareness the use of other types of therapy was reduced. Drug compliance had significant association with disease awareness.
CONCLUSIONS: Our patients with ulcerative colitis had poor disease awareness. Since awareness affected treatment compliance, the study emphasizes the need for better education of the patients and their family about the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11206883

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  2 in total

1.  Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease.

Authors:  Anilga Moradkhani; Lauren Kerwin; Sharon Dudley-Brown; James H Tabibian
Journal:  Dig Dis Sci       Date:  2011-05-03       Impact factor: 3.199

2.  Medication-Related Knowledge and Medication Adherence in Pediatric and Adolescent Patients with Inflammatory Bowel Disease.

Authors:  Jong Keon Lim; Yeoun Joo Lee; Jae Hong Park
Journal:  J Korean Med Sci       Date:  2020-04-13       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.